Bayer, Merial Fetch Win In Flea Medication MDL

Law360, New York (March 19, 2013, 5:53 PM EDT) -- A federal judge on Tuesday tossed multidistrict litigation claiming Bayer HealthCare LLC’s Advantage and Merial Ltd.’s Frontline flea and tick medications are ineffective and accusing the companies of running deceptive advertisements for the products.

The plaintiffs said that advertisements for Frontline and Advantage had falsely claimed the products are self-dispersing and attach to the entire body of the dog or cat after being applied in just one area and that they do not enter the pet’s bloodstream. But the judge said there is no evidence the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.